Please enable JavaScript to continue using this application.

Compare $ELDN vs $PEPG | Chartloom

Compare

$ELDN vs $PEPG

Eledon Pharmaceuticals Inc · PepGen Inc

ELDN

Eledon Pharmaceuticals Inc

PEPG

PepGen Inc

Compare $ELDN vs $PEPG

Comparing Eledon Pharmaceuticals Inc and PepGen Inc

ELDNEledon Pharmaceuticals Inc

PEPGPepGen Inc

ELDNEledon Pharmaceuticals Inc

Market cap

$191M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.1%

52W performance

-13.6%

FCF yield

-38.6%

PEPGPepGen Inc

Market cap

$181M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.5%

52W performance

-46.2%

FCF yield

-38.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ELDN

PEPG

Detailed metrics comparison

ELDN

Eledon Pharmaceuticals Inc

PEPG

PepGen Inc

Market Cap

ELDN$191M

PEPG$181M

Enterprise Value

ELDN$185M

PEPG$158M

Price

ELDN$2.48

PEPG$2.62

P/E Ratio

ELDNN/A

PEPGN/A

P/S Ratio

ELDN0.00x

PEPG0.00x

EV/Sales

ELDN0.00x

PEPG0.00x

EV/EBITDA

ELDN0.00x

PEPG0.00x

P/B Ratio

ELDN2.81x

PEPG1.32x

P/FCF Ratio

ELDNN/A

PEPGN/A

EV/FCF

ELDN-2.50x

PEPG-2.28x

PEG Ratio

ELDNN/A

PEPGN/A

Forward P/E (NTM)

ELDNN/A

PEPGN/A

Forward P/S (NTM)

ELDNN/A

PEPGN/A

Revenue (TTM)

ELDN$0

PEPG$0

Revenue Growth (YoY)

ELDNN/A

PEPGN/A

Forward Rev Growth

ELDN325.8%

PEPG408.5%

Gross Margin (TTM)

ELDN0.0%

PEPG0.0%

Operating Margin (TTM)

ELDN0.0%

PEPG0.0%

EBITDA Margin (TTM)

ELDN0.0%

PEPG0.0%

Net Margin (TTM)

ELDN0.0%

PEPG0.0%

FCF Margin (TTM)

ELDNN/A

PEPGN/A

Net Income (TTM)

ELDN$-99M

PEPG$-72M

FCF (TTM)

ELDN$-74M

PEPG$-69M

EPS (TTM)

ELDN-$0.87

PEPG-$1.04

ROE (TTM)

ELDN-9848.0%

PEPG-5101.0%

ROA (TTM)

ELDN-6897.0%

PEPG-4349.0%

ROIC (TTM)

ELDN-9848.0%

PEPG-5101.0%

Cash

ELDN$7M

PEPG$23M

Debt

ELDN$0

PEPG$0

Net Cash/Debt

ELDN$7M

PEPG$23M

Current Ratio (TTM)

ELDN7.90x

PEPG13.36x

Quick Ratio (TTM)

ELDN7.60x

PEPG13.02x

Debt/Equity (TTM)

ELDN0.00x

PEPG0.00x

Debt/Assets (TTM)

ELDN0.0%

PEPG0.0%

Interest Coverage (TTM)

ELDNN/A

PEPGN/A

Net Debt/EBITDA (TTM)

ELDN0.00x

PEPG0.00x

Beta

ELDN1.01

PEPG2.00

52W Performance

ELDN-13.6%

PEPG-46.2%

YTD Performance

ELDN53.1%

PEPG-63.5%

% from 52W High

ELDN-46.1%

PEPG-66.4%

% from 52W Low

ELDN83.7%

PEPG100.0%

Asset Turnover (TTM)

ELDN0.00x

PEPG0.00x

FCF Yield (TTM)

ELDN-38.6%

PEPG-38.3%

Earnings Yield (TTM)

ELDN-51.5%

PEPG-39.7%

Dividend Yield (TTM)

ELDNN/A

PEPGN/A

Rule of 40

ELDN0.0

PEPG0.0

EV/GP/RG

ELDNN/A

PEPGN/A

Ticker research

View ELDN research View PEPG research

Metric	ELDN Eledon Pharmaceuticals Inc	PEPG PepGen Inc
Market & Valuation
Market Cap	$191M	$181M
Enterprise Value	$185M	$158M
Price	$2.48	$2.62
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.81x	1.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.50x	-2.28x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	325.8%	408.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-72M
FCF (TTM)	$-74M	$-69M
EPS (TTM)	-$0.87	-$1.04
ROE (TTM)	-9848.0%	-5101.0%
ROA (TTM)	-6897.0%	-4349.0%
ROIC (TTM)	-9848.0%	-5101.0%
Financial Health
Cash	$7M	$23M
Debt	$0	$0
Net Cash/Debt	$7M	$23M
Current Ratio (TTM)	7.90x	13.36x
Quick Ratio (TTM)	7.60x	13.02x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	2.00
52W Performance	-13.6%	-46.2%
YTD Performance	53.1%	-63.5%
% from 52W High	-46.1%	-66.4%
% from 52W Low	83.7%	100.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-38.6%	-38.3%
Earnings Yield (TTM)	-51.5%	-39.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ELDN research	View PEPG research

Valuation

P/S Ratio

ELDN

0.00x

PEPG

0.00x

EV/FCF

ELDN

-2.50x

PEPG

-2.28x

Growth & revenue

Forward Revenue Growth

PEPG

408.5%

ELDN

325.8%

Profitability & performance

Gross Margin

ELDN

0.0%

PEPG

0.0%

ROE

PEPG

-5101.0%

ELDN

-9848.0%

FCF Yield %

PEPG

-38.3%

ELDN

-38.6%

52-Week Performance

ELDN

-13.6%

PEPG

-46.2%

Detailed metrics comparison

ELDN

Eledon Pharmaceuticals Inc

PEPG

PepGen Inc

Market Cap

ELDN$191M

PEPG$181M

Enterprise Value

ELDN$185M

PEPG$158M

Price

ELDN$2.48

PEPG$2.62

P/E Ratio

ELDNN/A

PEPGN/A

P/S Ratio

ELDN0.00x

PEPG0.00x

EV/Sales

ELDN0.00x

PEPG0.00x

EV/EBITDA

ELDN0.00x

PEPG0.00x

P/B Ratio

ELDN2.81x

PEPG1.32x

P/FCF Ratio

ELDNN/A

PEPGN/A

EV/FCF

ELDN-2.50x

PEPG-2.28x

PEG Ratio

ELDNN/A

PEPGN/A

Forward P/E (NTM)

ELDNN/A

PEPGN/A

Forward P/S (NTM)

ELDNN/A

PEPGN/A

Revenue (TTM)

ELDN$0

PEPG$0

Revenue Growth (YoY)

ELDNN/A

PEPGN/A

Forward Rev Growth

ELDN325.8%

PEPG408.5%

Gross Margin (TTM)

ELDN0.0%

PEPG0.0%

Operating Margin (TTM)

ELDN0.0%

PEPG0.0%

EBITDA Margin (TTM)

ELDN0.0%

PEPG0.0%

Net Margin (TTM)

ELDN0.0%

PEPG0.0%

FCF Margin (TTM)

ELDNN/A

PEPGN/A

Net Income (TTM)

ELDN$-99M

PEPG$-72M

FCF (TTM)

ELDN$-74M

PEPG$-69M

EPS (TTM)

ELDN-$0.87

PEPG-$1.04

ROE (TTM)

ELDN-9848.0%

PEPG-5101.0%

ROA (TTM)

ELDN-6897.0%

PEPG-4349.0%

ROIC (TTM)

ELDN-9848.0%

PEPG-5101.0%

Cash

ELDN$7M

PEPG$23M

Debt

ELDN$0

PEPG$0

Net Cash/Debt

ELDN$7M

PEPG$23M

Current Ratio (TTM)

ELDN7.90x

PEPG13.36x

Quick Ratio (TTM)

ELDN7.60x

PEPG13.02x

Debt/Equity (TTM)

ELDN0.00x

PEPG0.00x

Debt/Assets (TTM)

ELDN0.0%

PEPG0.0%

Interest Coverage (TTM)

ELDNN/A

PEPGN/A

Net Debt/EBITDA (TTM)

ELDN0.00x

PEPG0.00x

Beta

ELDN1.01

PEPG2.00

52W Performance

ELDN-13.6%

PEPG-46.2%

YTD Performance

ELDN53.1%

PEPG-63.5%

% from 52W High

ELDN-46.1%

PEPG-66.4%

% from 52W Low

ELDN83.7%

PEPG100.0%

Asset Turnover (TTM)

ELDN0.00x

PEPG0.00x

FCF Yield (TTM)

ELDN-38.6%

PEPG-38.3%

Earnings Yield (TTM)

ELDN-51.5%

PEPG-39.7%

Dividend Yield (TTM)

ELDNN/A

PEPGN/A

Rule of 40

ELDN0.0

PEPG0.0

EV/GP/RG

ELDNN/A

PEPGN/A

Ticker research

View ELDN research View PEPG research

Metric	ELDN Eledon Pharmaceuticals Inc	PEPG PepGen Inc
Market & Valuation
Market Cap	$191M	$181M
Enterprise Value	$185M	$158M
Price	$2.48	$2.62
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.81x	1.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.50x	-2.28x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	325.8%	408.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-72M
FCF (TTM)	$-74M	$-69M
EPS (TTM)	-$0.87	-$1.04
ROE (TTM)	-9848.0%	-5101.0%
ROA (TTM)	-6897.0%	-4349.0%
ROIC (TTM)	-9848.0%	-5101.0%
Financial Health
Cash	$7M	$23M
Debt	$0	$0
Net Cash/Debt	$7M	$23M
Current Ratio (TTM)	7.90x	13.36x
Quick Ratio (TTM)	7.60x	13.02x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	2.00
52W Performance	-13.6%	-46.2%
YTD Performance	53.1%	-63.5%
% from 52W High	-46.1%	-66.4%
% from 52W Low	83.7%	100.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-38.6%	-38.3%
Earnings Yield (TTM)	-51.5%	-39.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ELDN research	View PEPG research